Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

The obesity paradox in pulmonary arterial hypertension: the Scottish perspective.

McLean LL, Pellino K, Brewis M, Peacock A, Johnson M, Church AC.

ERJ Open Res. 2019 Nov 25;5(4). pii: 00241-2019. doi: 10.1183/23120541.00241-2019. eCollection 2019 Oct.

2.

Short-Term Hemodynamic Effects of Apelin in Patients With Pulmonary Arterial Hypertension.

Brash L, Barnes GD, Brewis MJ, Church AC, Gibbs SJ, Howard LSGE, Jayasekera G, Johnson MK, McGlinchey N, Onorato J, Simpson J, Stirrat C, Thomson S, Watson G, Wilkins MR, Xu C, Welsh DJ, Newby DE, Peacock AJ.

JACC Basic Transl Sci. 2018 Mar 28;3(2):176-186. doi: 10.1016/j.jacbts.2018.01.013. eCollection 2018 Apr.

3.

The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension.

Price LC, Dimopoulos K, Marino P, Alonso-Gonzalez R, McCabe C, Kemnpy A, Swan L, Boutsikou M, Al Zahrani A, Coghlan GJ, Schreiber BE, Howard LS, Davies R, Toshner M, Pepke-Zaba J, Church AC, Peacock A, Corris PA, Lordan JL, Gaine S, Condliffe R, Kiely DG, Wort SJ.

Thorax. 2017 Nov;72(11):1035-1045. doi: 10.1136/thoraxjnl-2016-209725. Epub 2017 Sep 12. Review.

PMID:
28904006
4.

A study of clinical and physiological relations of daily physical activity in precapillary pulmonary hypertension.

Panagiotou M, Johnson MK, Louvaris Z, Baker JS, Church AC, Peacock AJ, Vogiatzis I.

J Appl Physiol (1985). 2017 Oct 1;123(4):851-859. doi: 10.1152/japplphysiol.00986.2016. Epub 2017 Jun 29.

5.

Validation of impedance cardiography in pulmonary arterial hypertension.

Panagiotou M, Vogiatzis I, Jayasekera G, Louvaris Z, Mackenzie A, Mcglinchey N, Baker JS, Church AC, Peacock AJ, Johnson MK.

Clin Physiol Funct Imaging. 2018 Mar;38(2):254-260. doi: 10.1111/cpf.12408. Epub 2017 Feb 6.

PMID:
28168802
6.

Pulmonary vascular and cardiac impairment in interstitial lung disease.

Panagiotou M, Church AC, Johnson MK, Peacock AJ.

Eur Respir Rev. 2017 Jan 17;26(143). pii: 160053. doi: 10.1183/16000617.0053-2016. Print 2017 Jan. Review.

7.

Dynamic near-infrared spectroscopy assessment as an important tool to explore pulmonary arterial hypertension pathophysiology.

Panagiotou M, Vogiatzis I, Louvaris Z, Jayasekera G, McKenzie A, Mcglinchey N, Baker JS, Church AC, Peacock AJ, Johnson MK.

Eur Respir J. 2017 Jan 4;49(1). pii: 1602161. doi: 10.1183/13993003.02161-2016. Print 2017 Jan. No abstract available.

8.

Near infrared spectroscopy for the assessment of peripheral tissue oxygenation in pulmonary arterial hypertension.

Panagiotou M, Vogiatzis I, Louvaris Z, Jayasekera G, MacKenzie A, Mcglinchey N, Baker JS, Church AC, Peacock AJ, Johnson MK.

Eur Respir J. 2016 Oct;48(4):1224-1227. doi: 10.1183/13993003.01022-2016. Epub 2016 Sep 1. No abstract available.

9.

BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults.

Davidson AC, Banham S, Elliott M, Kennedy D, Gelder C, Glossop A, Church AC, Creagh-Brown B, Dodd JW, Felton T, Foëx B, Mansfield L, McDonnell L, Parker R, Patterson CM, Sovani M, Thomas L; BTS Standards of Care Committee Member, British Thoracic Society/Intensive Care Society Acute Hypercapnic Respiratory Failure Guideline Development Group, On behalf of the British Thoracic Society Standards of Care Committee.

Thorax. 2016 Apr;71 Suppl 2:ii1-35. doi: 10.1136/thoraxjnl-2015-208209. No abstract available. Erratum in: Thorax. 2017 Jun;72 (6):588.

PMID:
26976648
10.

Severe pulmonary hypertension in lung disease: phenotypes and response to treatment.

Brewis MJ, Church AC, Johnson MK, Peacock AJ.

Eur Respir J. 2015 Nov;46(5):1378-89. doi: 10.1183/13993003.02307-2014. Epub 2015 Aug 20.

11.

Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate.

Menni C, Graham D, Kastenmüller G, Alharbi NH, Alsanosi SM, McBride M, Mangino M, Titcombe P, Shin SY, Psatha M, Geisendorfer T, Huber A, Peters A, Wang-Sattler R, Xu T, Brosnan MJ, Trimmer J, Reichel C, Mohney RP, Soranzo N, Edwards MH, Cooper C, Church AC, Suhre K, Gieger C, Dominiczak AF, Spector TD, Padmanabhan S, Valdes AM.

Hypertension. 2015 Aug;66(2):422-9. doi: 10.1161/HYPERTENSIONAHA.115.05544. Epub 2015 Jun 1.

12.

The reversal of pulmonary vascular remodeling through inhibition of p38 MAPK-alpha: a potential novel anti-inflammatory strategy in pulmonary hypertension.

Church AC, Martin DH, Wadsworth R, Bryson G, Fisher AJ, Welsh DJ, Peacock AJ.

Am J Physiol Lung Cell Mol Physiol. 2015 Aug 15;309(4):L333-47. doi: 10.1152/ajplung.00038.2015. Epub 2015 May 29.

13.

Pulmonary hypertension in POEMS syndrome: resolution following radiotherapy.

Brewis MJ, Church AC, Peacock AJ, Thomson S, Tighe J, Johnson MK.

Pulm Circ. 2014 Dec;4(4):732-5. doi: 10.1086/678553.

14.

How should we best determine the need for inflight oxygen in patients with pulmonary arterial hypertension?

Burns RM, Johnson MK, Church AC.

Thorax. 2013 Jul;68(7):680. doi: 10.1136/thoraxjnl-2013-203344. Epub 2013 Feb 15. No abstract available.

PMID:
23417719
15.

Review of the British Thoracic Society winter meeting 2012, 5 to 7 December, London, UK.

Bayes HK, Church AC, Fisher AJ; BTS Science and Research Committee.

Thorax. 2013 Mar;68(3):277-82. doi: 10.1136/thoraxjnl-2012-203165. Epub 2013 Jan 12.

PMID:
23315491
16.

Hypoxaemia in patients with pulmonary arterial hypertension during simulated air travel.

Burns RM, Peacock AJ, Johnson MK, Church AC.

Respir Med. 2013 Feb;107(2):298-304. doi: 10.1016/j.rmed.2012.10.007. Epub 2012 Nov 3.

17.

Review of the British Thoracic Society Winter Meeting 2011, 7-9 December, London, U.K.

Bayes HK, Church AC, Fisher AJ; BTS Science and Research Committee.

Thorax. 2012 Mar;67(3):258-62. doi: 10.1136/thoraxjnl-2012-201597.

PMID:
22344397
18.

The effects of reward quality on risk-sensitivity in Rattus norvegicus.

Craft BB, Church AC, Rohrbach CM, Bennett JM.

Behav Processes. 2011 Sep;88(1):44-6. doi: 10.1016/j.beproc.2011.07.002. Epub 2011 Jul 27.

PMID:
21801819
19.

Non-invasive stroke volume measurement by cardiac magnetic resonance imaging and inert gas rebreathing in pulmonary hypertension.

McLure LE, Brown A, Lee WN, Church AC, Peacock AJ, Johnson MK.

Clin Physiol Funct Imaging. 2011 May;31(3):221-6. doi: 10.1111/j.1475-097X.2010.01004.x. Epub 2011 Jan 7.

PMID:
21470362
20.

Aspiration and development of subglottic stenosis in patients with Wegener's granulomatosis.

Church AC, Goldsmith K, Sivasothy P.

J Laryngol Otol. 2010 Apr;124(4):393-6. doi: 10.1017/S0022215109991952. Epub 2009 Nov 25.

PMID:
19930784
21.

Epoprostenol use in a National Pulmonary Hypertension Centre from 1997 to 2007.

Church AC, Sanabria D, Peacock A, Johnson M.

Thorax. 2009 Jul;64(7):642. doi: 10.1136/thx.2008.110643. No abstract available.

PMID:
19561289
22.

Mediastinal abscess after lung transplantation secondary to Burkholderia gladioli infection.

Church AC, Sivasothy P, Parmer J, Foweraker J.

J Heart Lung Transplant. 2009 May;28(5):511-4. doi: 10.1016/j.healun.2009.01.019. Epub 2009 Apr 5. Review.

PMID:
19416783
23.

A case of refractory hypoxaemia.

Church AC, Fuld JP, Screaton N, Chilvers ER.

Postgrad Med J. 2008 Aug;84(994):442-4. doi: 10.1136/pgmj.2008.071068. No abstract available.

PMID:
18832407
24.

Odd behaviour in the airport arrivals lounge--what is the diagnosis?

Peake ST, Church AC, Dubrey SW.

QJM. 2007 Jul;100(7):461. Epub 2007 Jun 12. No abstract available.

PMID:
17566008
25.

An uncommon cause of heart failure.

Church AC, Quinnell T.

QJM. 2007 Feb;100(2):139. Epub 2006 Dec 12. No abstract available.

PMID:
17164323
26.
27.

Clinical advances in therapies targeting the interleukin-2 receptor.

Church AC.

QJM. 2003 Feb;96(2):91-102. Review. No abstract available.

PMID:
12589007
28.

X-linked severe combined immunodeficiency.

Church AC.

Hosp Med. 2002 Nov;63(11):676-80. Review.

PMID:
12474613
29.

Complementary memory storage sites in mice: their development as affected by the competitive NMDA receptor antagonist, CPP.

Church AC, Flexner JB, Flexner LB.

Pharmacol Biochem Behav. 1995 Sep;52(1):237-40.

PMID:
7501672
30.
31.

Long-term suppression in mice of the development of complementary memory storage sites: effect of a muscarinic antagonist.

Flexner LB, Flexner JB, Church AC.

Pharmacol Biochem Behav. 1991 Jul;39(3):689-94.

PMID:
1784597
32.

Long-term suppression of the cerebral spread of a memory: effects of idazoxan and clonidine.

Church AC, Flexner LB, Flexner JB, Reynolds EE.

Pharmacol Biochem Behav. 1989 Mar;32(3):749-56.

PMID:
2544908
33.

Blockade of beta 1- but not of beta 2-adrenergic receptors replicates propranolol's suppression of the cerebral spread of an engram in mice.

Flexner JB, Flexner LB, Church AC, Rainbow TC, Brunswick DJ.

Proc Natl Acad Sci U S A. 1985 Nov;82(21):7458-61.

34.

Blockade of peripheral beta-adrenergic receptors fails to suppress the cerebral spread of an engram in mice.

Church AC, Flexner JB, Flexner LB, Rainbow TC.

Pharmacol Biochem Behav. 1985 Jul;23(1):27-31.

PMID:
2994119
35.

Posttraumatic autoimmune reaction in peripheral nerve: effect of a single injury.

de Medinaceli L, Church AC, Wang YN.

Exp Neurol. 1985 May;88(2):372-84.

PMID:
3987862
36.

Posttraumatic autoimmune reaction in peripheral nerve: effect of two successive injuries at different locations.

de Medinaceli L, Church AC, Wang YN.

Exp Neurol. 1985 May;88(2):396-404.

PMID:
3886421
37.

Posttraumatic autoimmune reaction in peripheral nerve: effect of two successive injuries at the same site.

de Medinaceli L, Church AC, Wang YN.

Exp Neurol. 1985 May;88(2):385-95.

PMID:
3886420
38.

Visual discrimination learning and interhemispheric transfer in the cat, as affected by 6-hydroxydopamine.

Sprague JM, Church AC, Liu CN, Chambers WW, Flexner LB.

Exp Brain Res. 1985;61(1):43-53.

PMID:
3936728
39.

Localization of Met5-enkephalin-Arg6-Phe7-like immunoreactivity in the rat gastrointestinal tract.

Wang YN, Church AC, Wyatt RJ.

Neurosci Lett. 1984 Oct 26;51(3):319-24.

PMID:
6395044
40.

The effect of the beta-adrenergic receptor antagonist, propranolol, on the cerebral spread of a memory trace in mice.

Flexner LB, Church AC, Flexner JB, Rainbow TC.

Pharmacol Biochem Behav. 1984 Oct;21(4):633-9.

PMID:
6095325
41.
42.

Studies on memory: the cerebral spread of an engram in mice as affected by inhibitors of dopamine beta-hydroxylase.

Flexner JB, Flexner LB, Church AC.

Pharmacol Biochem Behav. 1983 Apr;18(4):519-23.

PMID:
6867057
43.
44.

The cyclized C-terminal dipeptide of arginine vasopressin: metabolic stability and antagonism of puromycin-induced amnesia.

Walter R, Hoffman PL, Church AC, Flexner JB, Flexner LB.

Horm Behav. 1982 Jun;16(2):234-44. No abstract available.

PMID:
7118089
45.

Neuronal localization of dopamine-sensitive adenylate cyclase within the rat olfactory tubercle.

Church AC, Bunney BS, Krieger NR.

Brain Res. 1982 Feb 25;234(2):369-76.

PMID:
6800567
46.

Alcohol intake in selected lines of mice: importance of sex and genotype.

Church AC, Fuller JL, Dann L.

J Comp Physiol Psychol. 1979 Apr;93(2):242-6.

PMID:
457948
47.
48.

Behavioral effects of salsolinol and ethanol on mice selected for sensitivity to alcohol-induced sleep time.

Church AC, Fuller JL, Dudek BC.

Drug Alcohol Depend. 1977 Sep-Nov;2(5-6):443-52.

PMID:
913242
49.

Salsolinol differentially affects mice selected for sensitivity to alcohol.

Church AC, Fuller JL, Dudek BC.

Psychopharmacology (Berl). 1976 May 5;47(1):49-52.

PMID:
959467

Supplemental Content

Loading ...
Support Center